CTOs on the Move

Occupational Health and Hygiene Corporation of A

www.ohhca.com

 
Occupational Health and Hygiene Corporation of America is a Lebanon, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ohhca.com
  • 419 Ransdell Rd
    Lebanon, IN USA 46052
  • Phone: 765.482.7652

Executives

Name Title Contact Details

Similar Companies

ForeverGreen

ForeverGreen Worldwide Corporation develops, manufactures and distributes an expansive line of all natural whole foods and products to North America, Australia, Europe, Asia, Africa and South America, including their new global Xpress offering Prodigy-5. Additional products include PowerStrips, SolarStrips and BeautyStrips. They also offer their North America weight-management line Ketopia, along with FrequenSea, a whole-food beverage with industry exclusive marine phytoplankton, immune support and weight management products, and Pulse-8 powdered L-arginine formula.

Global Health Systems Inc

Global Health Systems Inc is a Aliso Viejo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Digisonics

For more than 35 years, Digisonics has provided best-of-class interpretation systems for cardiology and OB/GYN to many of the leading hospitals, clinics, private offices, and research sites around the world.

Acuitec

Acuitec is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Birmingham, AL. To find more information about Acuitec, please visit www.acuitec.com

Enterin Inc.

Enterin is pioneering the medical community`s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease. We are leveraging years of research to become the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha- synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson`s disease. In the gut, this results in improved motility. We are now progressing this drug through clinical trials in an attempt to reverse the constipation of Parkinson`s disease. Our long-term mission is to become the world leader in developing pharmaceutical therapies that repair the gut-brain axis.